US authorises Pfizer oral Covid-19 pill Paxlovid for home treatment | South China Morning Post

The US Food and Drug Administration on December 22, 2021, approved the use of Pfizer’s Paxlovid pill for emergency use for treating mild-to-moderate disease in Covid-19 patients aged 12 or older. Pfizer’s clinical data shows the drug is 90 per cent effective in preventing hospitalisations and deaths in patients at h…

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.